优先股转换完成与资本结构简化 - 公司已完成优先股转换 97%的附股息可转换优先股按每股0.25美元转换为普通股 剩余3%代表应计股息的股份按每股0.10美元转换为普通股 [1] - 此次转换消除了所有附股息优先股类别及相关资产负债表负债 使公司成为一家实质上无债务的公司 [4] - 转换价格（普通股0.25美元）较当前市价存在85%的溢价 反映了股东对公司未来的信心 [4][6] 转换后股权结构与流动性影响 - 转换后 公司已发行普通股为27,309,271股 公众流通股为10,524,984股 [2] - 公司管理层持有2,200,000份可转换为普通股的认股权证 若行权将为公司提供未来运营资金 完全稀释后的总普通股为29,509,271股 [3] - 优先股转换为普通股 应有助于为在场外市场交易的GLUC股票创造额外的流动性 [2] 剩余优先股与公司治理 - 公司仅存的优先股为1,000股投票优先股 由董事会成员Christopher J. Jemapete和Edmund J. Burke持有 [5] - 这些股份旨在提供公司章程规定的特定投票权 不附带转换权或股息权 [5] 业务运营与市场表现 - 公司旗舰品牌GlucoDown在亚马逊上已获得近12,000条评论 所有口味均获得消费者最高评级 [6] - GlucoDown已在全国范围内精选的Walgreens和CVS药店的糖尿病护理专区销售 [7] - 新推出的品牌Fiber Up使公司进入可溶性纤维补充剂市场 与Metamucil竞争 [6] - 得益于品牌在亚马逊和主要零售商处的高知名度 公司估计其股东基数现已超过1,000名个人投资者 [6] 行业定位与发展战略 - 公司专注于可溶性纤维营养的业务 与美国国家公共卫生优先事项高度契合 膳食纤维因在美国人口中普遍摄入不足 已被美国卫生与公众服务部及农业部正式指定为“公共卫生关注营养素” [8] - 公司不断扩大的产品组合 包括可溶性纤维饮料混合物以及计划推出的苏打水、风味水、营养棒等 使其处于该公共卫生倡议的前沿 并站在消费者对易获取代谢健康解决方案需求的前列 [9]

NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an investigational vaccine-alternative monoclonal antibody candidate for the prevention of COVID. Fast Track is a process that enables the FDA to expedite the development and review of new drugs that address a serious or life-threatening condition and fill an unmet medical need. If relevant criteria are met, programs ...

In‑store sales dominate: 88% of total spending happened in-store and 12% online Total e‑commerce sales increased 7% compared to the prior year, reflecting total value of online purchases across all retail categoriesClothing and accessories sales grew 10%, leading all retail segments TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Visa, a global leader in digital payments, today released its annual Retail Spend Monitor from Visa Consulting & Analytics (VCA), offering a comprehensive view of Canada’s holiday retai ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID versus placebo, at three months, from a single intramuscular (IM) dose, with protection beyond three months anticipated  A second arm will evaluate monthly IM doses versus placebo to demonstrate the safety and efficacy of more frequent dosing to support individual choice should at-risk persons seek periodic extra protection from COVIDPrimary endpoint is the reduct ...

NEW YORK and AMSTERDAM, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments, today announced its common stock has been added to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 22, 2025. “2025 has been a defining year for AtaiBeckley, marked by meaningful ...

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Glen Burnie Bancorp (“Bancorp”) (OTCQX: GLBZ), the holding company for The Bank of Glen Burnie (the “Bank”), has qualified to trade on the OTCQX® Best Market. Glen Burnie Bancorp previously traded on Nasdaq. Glen Burnie Bancorp begins trading today on OTCQX under the symbol “GLBZ.” U.S. investors can find current financial discl ...

HONG KONG SAR, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (Nasdaq: MIMI) (“Mint” or the “Company”), a leading Hong Kong-based technology company and interior design and fit out works provider, today announced that the Company had received a notification letter (the “Notification Letter”) dated December 19, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is currently not in compliance with the minimum bid price require ...

SINGAPORE, Dec. 23, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a significant acceleration of its longevity and regenerative medicine strategy with the launch of a comprehensive stem cell therapy platform and establishment of its first clinic in Shenzhen, China. This strategic advancement builds on the Company’s earlier acquisition of distrib ...

ORLANDO, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) today announced the retirement of EJ Elliott, who serves as the Executive Chairman of the Company’s Board of Directors (the “Board”), effective December 31, 2025. EJ Elliott founded the Company in 1968 and has been Chairman of the Board since 1968. He served as the Chief Executive Officer of the Company from 1968 to 2016. In connection with EJ Elliott’s retirement, the Board of Director ...

SALT LAKE CITY, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, today responded to the Federal Communications Commission’s (FCC) announcement to immediately implement Section 1709 of the FY25 National Defense Authorization Act (NDAA). The FCC’s action adds foreign-manufactured drones and their critical components to the Covered List effective immediately. This step was taken f ...